CSI Market
Sign In | Register

Viridian Therapeutics Inc (VRDN) Annual Balance Sheets

Annual · GAAP · USD millions
Access VRDN quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Viridian Therapeutics Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Available-for-sale Securities, Debt Securities, Current MA662.27
Cash & Short-term Investments662.00
Other Current Assets212.38
Prepaid Expense And Other Assets Current19.58
Total Current Assets894.23
Equipment/Property/Plant Net1.23
Other Assets, Noncurrent3.96
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents212.38
Unbilled Receivables Related Party Current-
Operating Lease Right Of Use Asset2.42
Total Assets899.42
Liabilities
Accounts Payable, Current AC8.68
Accrued Liabilities, Current AC62.01
Other Liabilities, Current0.00
Total Current Liabilities70.70
Long-term debt49.94
Secured Debt49.94
Other Long-term Debt, Noncurrent OT34.24
Total Long-term Debt84.18
Derivative Liability, Noncurrent DE20.03
Other liabilities, Noncurrent2.34
Contract With Customer Liability Current-
Other Liabilities Related Party Noncurrent-
Contract With Customer Liability Noncurrent-
Total Liabilities177.25
Stockholders' Equity
Common Stock Value1.02
Additional Paid In Capital Common Stock1,927.10
Retained Earnings / Accumulated Deficit-1,338.46
Other Equity71.32
Common Stockholder's Equity660.98
Preferred Stockholder's Equity61.19
Total Stockholder's Equity722.17
Liabilities & Stockholder's Equity899.42
4 historic quarters locked

Sign in to unlock the full Viridian Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Viridian Therapeutics Inc de Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: vrdn-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001590750-26-000007

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.